Oncogenes: new targets in cancer treatment

Oncogenes: new targets in cancer treatment

This thesis is submitted in partial fulfilment of the requirements for the degree of Bachelor of Pharmacy, 2019.

Bibliografische gegevens
Hoofdauteur:	Chowdhury, Waseka Shams
Andere auteurs:	Kabir, Eva Rahman
Formaat:	Thesis
Taal:	English
Gepubliceerd in:	Brac University 2020
Onderwerpen:	Cancer Genes Proliferation Metastasis Oncogenes Drug Design.
Online toegang:	http://hdl.handle.net/10361/13768

Gelijkaardige items

A review of Breast Cancer risk factor assessment on women in developing countries, cancer drug resistance, and Breast Cancer treatment in Bangladesh
door: Raihan, Dilraj
Gepubliceerd in: (2024)

Role of statins as antagonists of SPARC in gastric cancer
door: Shahmat, Rad
Gepubliceerd in: (2019)

Comparison of conventional doxorubicin with liposome encapsulated doxorubicin as a treatment of breast cancer-a review
door: Akter, Honufa
Gepubliceerd in: (2024)

Stem cell in cancer disease cure vs cause
door: Chowdhury, Marisha Mansur
Gepubliceerd in: (2023)

RIPK pathway, as a potential target, for cancer treatment - a review
door: Jahan, Nusrat
Gepubliceerd in: (2024)

Identification of the multi-drug resistant genes in the bacteria isolated from the saliva of smoker oral cancer patients and comparative analysis with smoker normal individuals
door: Hasan, Samir, et al.
Gepubliceerd in: (2024)

A review of endocannabinoid system and its pharmacological role as a drug target for cancer therapies
door: Khan, MD Salehin
Gepubliceerd in: (2024)

Arresting tumor cell proliferation and inhibition of AKT pathway via the use of multikinase inhibitor sorafenib forthe treatment of glioblastoma
door: Raju, Md. Ismail
Gepubliceerd in: (2022)

A comprehensive review on drug repurposing in cancer treatment
door: Sarkar, Onusree
Gepubliceerd in: (2024)

Prevalence and application of an evolving genome editing tool “CRISPR/Cas System” in cancer research and treatment
door: Shaikat, Mahdi Mubin
Gepubliceerd in: (2023)

SIRT6 and cancer stem cells: is there any implication?
door: Sarker, Tanosi
Gepubliceerd in: (2022)

Drug repurposing: potential of Antimicrobial Drugs in Breast Cancer Treatment
door: Chakraborty, Anuradha
Gepubliceerd in: (2024)

A review on potential of PARP inhibitors in the treatment of prostate cancer
door: Islam, Saidul
Gepubliceerd in: (2022)

Qualitative classification of the breast cancer genome and clustering of the cancer gene network
door: Fatema, Kaniz, et al.
Gepubliceerd in: (2019)

Targeted therapeutic options in the treatment of Breast Cancer
door: Alam, Kazi Tasnuva
Gepubliceerd in: (2022)

A study of glioblastoma gene profile
door: Nabila, Nusrat Jahan
Gepubliceerd in: (2024)

Targeted drug delivery using polymeric nanoparticles for the treatment of cancer: a review
door: Penheiro, Diandra Elizabeth
Gepubliceerd in: (2019)

A review on recent advances in drugs for lung cancer treatment
door: Noor, Fouzia
Gepubliceerd in: (2024)

Therapeutic prospective of targeting calcium homeostasis in cancer – a review
door: Kamal, Tasnova
Gepubliceerd in: (2019)

A review on nanoparticles based drug delivery in cancer treatment: advantages & challenges
door: Nahar, Kamrun
Gepubliceerd in: (2023)

Targeting DHFR in breast cancer: exploring expression patterns and identifying potential inhibitors through docking studies
door: Araf, Faiaz Fahim
Gepubliceerd in: (2024)

A review on RNAi technology and its therapeutic potential in Cancer
door: Mahaleka, Aarshi
Gepubliceerd in: (2024)

Pathway analysis of Disease-Gene associated network in the human breast cancer
door: Lamia
Gepubliceerd in: (2020)

Targeting BRAFV600E in the treatment of CRC
door: Roja, Mashwiyat Samrin
Gepubliceerd in: (2024)

A review on the recent advancements on nanoparticles drug delivery approaches in anti-cancer treatment
door: Hoque, Syeda Mehren
Gepubliceerd in: (2024)

A review on Single Nucleotide Polymorphism (SNPs) and their effect on cancer risk in South Asian population
door: Beruni, Sajid Mahmud Al
Gepubliceerd in: (2022)

A review on the potential of repurposing of metformin for colon cancer and breast cancer
door: Oishy, Jannatun Noor
Gepubliceerd in: (2024)

Risk of cancer associated with antihypertensive drugs
door: Iqbal, Adnan
Gepubliceerd in: (2024)

Computational insights into molecular docking strategies for non-small cell lung cancer drug discovery
door: Das, Reshita
Gepubliceerd in: (2024)

Association of XRCC1 and XPD polymorphism with risk of prostate cancer in Bangladesh population
door: Ahmed, Nafisa
Gepubliceerd in: (2023)

Current practice and approaches of immunotherapy in Cancer treatment
door: Khondokar, Faiza
Gepubliceerd in: (2022)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
door: Razna, Amrin Islam
Gepubliceerd in: (2019)

Survey on patients undergoing treatments for cervical, endometrial and ovarian cancer
door: Nawar, Anika
Gepubliceerd in: (2019)

Antihypertensive drugs and risk of cancer: A pharmacovigilance study
door: Rahman, Ahadina
Gepubliceerd in: (2018)

Genetic innovations for breast cancer treatment : a review of gene therapy strategies and future implications
door: Hasan, Sakib
Gepubliceerd in: (2024)

A review on carbon nanotube: a new era in cancer diagnosis & therapy
door: Parvez, Safi
Gepubliceerd in: (2023)

Breast cancer therapy through Liposomal drug delivery system
door: Ome, Nusrat Jahan
Gepubliceerd in: (2024)

Recent advancement on breast cancer detection and treatment
door: Rahman, Sanjida
Gepubliceerd in: (2023)